Mathilde Bonnet Selected Research

Post-Infectious Disorders

1/2022

AhR/IL-22 pathway as new target for the treatment of post-infectious irritable bowel syndrome symptoms.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mathilde Bonnet Research Topics

Disease

8	Neoplasms (Cancer) 07/2022 - 10/2014
6	Melanoma (Melanoma, Malignant) 01/2015 - 04/2010
5	Colorectal Neoplasms (Colorectal Cancer) 05/2021 - 03/2017
4	Inflammation (Inflammations) 01/2022 - 12/2014
3	Infections 01/2022 - 01/2020
3	Carcinogenesis 01/2020 - 12/2014
3	Neoplasm Metastasis (Metastasis) 01/2015 - 04/2010
1	Thrombotic Microangiopathies 07/2022
1	Adenocarcinoma 07/2022
1	Gastroenteritis 01/2022
1	Cognitive Dysfunction 01/2022
1	Post-Infectious Disorders 01/2022
1	Hypersensitivity (Allergy) 01/2022
1	Bronchiolitis 11/2019
1	Persistent Infection 01/2018
1	Cysts 01/2018
1	Microsatellite Instability 03/2017
1	Genomic Instability 03/2017
1	Dysbiosis 01/2016
1	Embolic Stroke 04/2015
1	Cardiac Tamponade 04/2015
1	Atrioventricular Block 04/2015
1	Colonic Neoplasms (Colon Cancer) 12/2014
1	Alzheimer Disease (Alzheimer's Disease) 06/2014
1	Fibrosarcoma 04/2010
1	Experimental Melanoma 04/2010

Drug/Important Bio-Agent (IBA)

5	colibactinIBA 05/2021 - 12/2014
3	Proteins (Proteins, Gene)FDA Link 03/2017 - 04/2010
3	Melanins (Melanin)IBA 01/2015 - 09/2012
2	Volatile Fatty AcidsIBA 01/2022 - 01/2020
2	N- (2- diethylaminoethyl)- 6- iodoquinoxaline- 2- carboxamideIBA 01/2015 - 09/2013
2	Radioisotopes (Radionuclides)IBA 09/2013 - 12/2011
1	gemcitabine triphosphateIBA 07/2022
1	Gemcitabine FDA Link 07/2022
1	Cytidine DeaminaseIBA 07/2022
1	130-nm albumin-bound paclitaxelIBA 07/2022
1	indoleIBA 01/2022
1	tryptopholIBA 01/2022
1	CytokinesIBA 01/2022
1	Interleukin-22 (IL-22)IBA 01/2022
1	Tryptophan (L-Tryptophan)FDA Link 01/2022
1	Biomarkers (Surrogate Marker)IBA 05/2021
1	DNA (Deoxyribonucleic Acid)IBA 03/2017
1	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 03/2017
1	TetraspaninsIBA 03/2017
1	MutagensIBA 03/2017
1	EnzymesIBA 06/2016
1	Peroxidase (Myeloperoxidase)IBA 06/2016
1	Fluorescent Dyes (Fluorescent Probes)IBA 06/2016
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2016
1	ImmunosorbentsIBA 06/2016
1	Virulence Factors (Pathogenicity Factors)IBA 01/2016
1	Iodine-123IBA 01/2015
1	AzoxymethaneIBA 12/2014
1	Dextrans (Dextran)FDA Link 12/2014
1	SodiumIBA 12/2014
1	InterleukinsIBA 12/2014
1	Proto-Oncogene Proteins c-metIBA 12/2014
1	Annexin A1IBA 10/2014
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 10/2014
1	Small Interfering RNA (siRNA)IBA 10/2014
1	Peptides (Polypeptides)IBA 10/2014
1	hyaluronate lyase (spreading factor)IBA 10/2014
1	Apoptosis Inducing FactorIBA 06/2014
1	CaspasesIBA 06/2014
1	pyridineIBA 09/2012
1	AcridinesIBA 12/2011
1	Galectin 1 (LGALS1)IBA 04/2010
1	lactate dehydrogenase 1 (LDH1)IBA 04/2010
1	Pyruvate KinaseIBA 04/2010
1	matrigelIBA 04/2010
1	Cathepsin DIBA 04/2010
1	SynteninsIBA 04/2010

Therapy/Procedure

3	Immunotherapy 01/2020 - 03/2017
3	Therapeutics 09/2019 - 12/2011
2	Radiotherapy 09/2019 - 01/2015
2	Drug Therapy (Chemotherapy) 09/2019 - 09/2013
1	Duration of Therapy 11/2019
1	Oral Administration 01/2018
1	Radioimmunotherapy 03/2017
1	Catheters 04/2015
1	Complementary Therapies (Alternative Medicine) 09/2013